News and events

Cutaneous leishmaniasis (CL) is a poverty related, neglected tropical disease, which is without an effective and cheap systemic treatment. The aim of TT4CL is to develop a new orally available drug for treatment of CL aimed towards registration ...
Read More
TT4CL (Targeted treatment for cutaneous leishmaniasis) is a new Horizon 2020-funded project which aims to reduce the burden of a Neglected Infectious (NID) and its social and economic impacts. Horizon 2020, the European Union’s (EU) research ...
Read More
Today we were delighted to welcome specialists from across the world to @StGeorgesUni to the TT4CL kick-off meeting. It has been an honour to host this event and we look forward to developing a new Leishmaniasis drug
Read More
We are delighted to announce that the grant agreement no. 815622 between the European Commission and 5 European partners and 1 Iranaian partner hes been signed on May 1, 2019. The name of the project is TT4CL, “targeted treatment for...
Read More

Subscribe to our newsletter